Massivemarkets

JAZZ

Jazz Pharmaceuticals, Inc.

Nasdaq · usd

$214.64-0.01 (+0.00%)
As of 9:13:23 AM EDT on Oct 23, 2026 · 15-minute delayed

Jazz Pharmaceuticals, Inc. (JAZZ) trades at $214.64 (+0.00%) as of 9:13:23 AM EDT on Oct 23, 2026, -8.61% over the past month. Market cap is $13.93B, with 6.5 days to cover in short interest.

Stock performance

How Jazz Pharmaceuticals, Inc. (JAZZ) stock has performed from one day to one year, with its 52-week range.

+1.73%
+$3.66 over 1D
$210.58$212.00$213.43$214.854:05 AM11:05 AM12:45 PM2:30 PM8:00 PM$214.65
1D
+1.26%
1W
+0.11%
1M
-8.61%
YTD
+26.26%
1Y
+54.95%
52-wk range
$128.80 – $266.38

Key statistics

Today's trading snapshot for JAZZ: day range, open, previous close, volume and market cap.

Day range
$210.26 – $215.24
Open
$211.38
Prev close
$214.65
Volume
783.81K
Market cap
$13.93B
Shares out
64.91M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Jazz Pharmaceuticals, Inc.: P/E, P/S, P/B, ROE and more.

P/E
14.81
P/S
3.03
P/B
2.90
P/FCF
9.20
ROE
19.6%
ROA
8.5%
Debt/Equity
0.91
Div yield
0.00%

As of Oct 22, 2026

8-K filings

Material corporate events Jazz Pharmaceuticals, Inc. has disclosed to the SEC on Form 8-K.

  • Executive leadershipOct 9, 2026

    On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the "Company"), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.

  • Debt activitySep 23, 2026

    “On September 23, 2026, Jazz Financing Lux S.à r.l. ... entered into Amendment No. 4 (the “Repricing Amendment”) to the Credit Agreement” to extend the maturity date and reprice the outstanding U.S. dollar term loan facility. The amendment changed the maturity date to May 5, 2033 from May 5, 2028 and amended the interest rate.

  • Deal completionsSep 15, 2026

    On September 15, 2026, Jazz Pharmaceuticals plc, an Irish public limited company (the "Company") issued a press release announcing the completion of the acquisition of Actio Biosciences, Inc., a Delaware corporation ("Actio"). Following the acquisition, Actio became a wholly-owned subsidiary of the Company.

  • Shareholder returnsAug 31, 2026

    The Company also repurchased approximately $225.0 million of its ordinary shares ... concurrently with the pricing of the offering ... and such repurchases were effected as part of the Company's share repurchase program announced in July 2024.

  • Business developmentsAug 25, 2026

    the U.S. Food and Drug Administration approved two Ziihera® (zanidatamab-hrii)-containing regimens for the first-line treatment of adults with unresectable locally advanced or metastatic HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA): Ziihera plus Tevimbra® (tislelizumab-jsgr) and chemotherapy (HER2+ IHC 3+ or IHC 2+/ISH+), and Ziihera plus chemotherapy (HER2+ IHC 3+).

JAZZ short interest

How heavily JAZZ is shorted: shares short, days to cover and average daily volume.

Days to cover
6.5
Short interest
5.48M
Avg volume
845.81K

As of · reported to FINRA twice monthly.

JAZZ news

The latest news and headlines about Jazz Pharmaceuticals, Inc. (JAZZ).

Frequently asked questions

What is the Jazz Pharmaceuticals, Inc. (JAZZ) stock price today?

Jazz Pharmaceuticals, Inc. (JAZZ) is trading at $214.64 (+0.00% on the day) as of 9:13:23 AM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Jazz Pharmaceuticals, Inc.?

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for…

What is the short interest in JAZZ?

As of Sep 30, 2026, JAZZ has 5.48M shares short and 6.5 days to cover.

What exchange is JAZZ listed on?

Jazz Pharmaceuticals, Inc. (JAZZ) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of JAZZ with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a JAZZ analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.